This big mover up over 130% in premarket 👀

Find out why                                                                                                                                                                                                                                                                                                                                                                                                                 May 30, 2023 | [Read Online]( Good day, 360 – Here are our top investing ideas today – these setups look primed! And make sure to put Jeff William’s complimentary Market Navigator day on your calendar for tomorrow (scroll down for info). ACON - Up over 130% in pre-market after commercial agreement with The London Clinic and London Spine Clinic GOTU - Up over 20% after crushing earnings LXRX - Up over 20% after FDA approval of INPEFA (™) for treatment of heart failure The markets are on FIRE🔥 and everyone wants in on the SPY Trade of the Day in Market Navigator! See why Jeff Williams’ Chat Room is THE place to be! 👉[Click here for complimentary training]( [Wed 9-11am, 2-4pm EST]( PS Special ⚡FLASH SALE pricing⚡MAY be available TOMORROW (Wednesday) – so tune in! ACON - Up over 130% in pre-market after commercial agreement with The London Clinic and London Spine Clinic Aclarion (ACON) is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS) in the United States. The company develops post-processing software. Today ACON announced that it had entered into a commercial agreement with the London Clinic and London Spine Clinic. The London Clinic is the UK's most renowned independent, private hospital, established in 1932. The London Spine Clinic is the first specialist spinal unit established in England in 1997. This will be ACON’s first customer in London. This agreement legitimizes the company’s software even further and investors are excited at the possibility of new revenue streams in England and beyond. The $1.23 level has acted as support in the pre-market and will be an important level to watch. Above it, the first major target for bulls is the pre-market high at $1.42. Beyond that, potential targets are $1.50, $1.70, $2 and then $2.37. Below $1.23, there is potential support at $1.10, $1, $0.82 and then a gap to fill at $0.59. GOTU - Up over 20% after crushing earnings Gaotu Techedu (GOTU) is a technology-driven education company, providing online K-12 after-school tutoring services in the People's Republic of China. GOTU reported Q1 adjusted EPADS of $0.07 vs $0.06 year-over-year with sales of $102.99 million beating the $41.41 million estimate. That’s around a 150% revenue estimate beat. GOTU also guided Q2 revenue at $94.71-$97.63 million versus the consensus $40.85 million. The earnings surprised analysts and the stock is trading up over 20% in the pre-market. The $3 area is an important level to watch as selling from that level turned into buying, and it now becomes a potential support level. Above it, the first major target for bulls is the pre market high of $3.14. Beyond that potential targets are $3.41, $4, $4.50 and $4.87. Below $3, there is potential support at $2.85, $2.70, and a gap to fill at $2.49. LXRX - Up over 20% after FDA approval of INPEFA (™) for treatment of heart failure Lexicon Pharmaceuticals (LXRX) focuses on the discovery, development and commercialization of pharmaceutical products. The company announced that its drug INPEFA was granted broad label across the full range of left ventricular ejection fraction for patients with or without diabetes. INEPFA is a once-daily oral tablet to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure. INPEFA reduced the risk of total occurrence of cardiovascular death, hospitalization for heart failure and urgent heart failure visits by 33% compared to placebo in the SOLOIST-WHF study. The $3.65-$3.70 area was resistance in the after-market and became an area of support in the pre-market. Above it, targets to the upside are at $3.80 and then the pre-market high of $4.14. Beyond that, targets are $4.50, $4.70, $5, $5.20 and $6. Below $3.65, there is potential support at $3.60, $3.40 and a gap to fill at $3.18. Economic Calendar ([() To Your Success!   Questions or concerns about our products? Email [Support@360wallstreet.io]( © Copyright 2022, RagingBull  DISCLAIMER To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at [( FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of https:// ragingbull. com or RagingBull.com LLC are paid in whole or in part by commission based on their sales of Services to subscribers. [RagingBull.com](, LLC shall be entitled to recover attorneys’ fees, costs and disbursements. In the event that any suit or action is instituted as a result of doing business with RagingBull. com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull. com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements in addition to any other relief to which it may be entitled. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication. [tw]( Update your email preferences or unsubscribe [here]( © 360wallstreet 62 Calef Hwy. #233 Lee, NH 03861, United States [[beehiiv logo]Powered by beehiiv](